Pfizer to launch cheaper version of J&J immune drug Remicade
Drugmaker Pfizer said Monday that it will launch a less-expensive version of rival Johnson & Johnson's blockbuster immune disorder drug, Remicade.
Oct 18, 2016
0
0
For patients who may benefit from a major liver operation to treat cancer, an open abdominal procedure is often the only option. However, a minimally invasive approach that avoids the large open incision may soon be a viable ...
Oct 18, 2016
Obesity during pregnancy puts women at higher risk for complications and can compromise the newborn's health. But obese women who undergo weight-loss (bariatric) operations before getting pregnant significantly lower their ...
Oct 18, 2016
Among patients undergoing incisional hernia repair, the use of mesh to reinforce the repair was associated with a lower risk of hernia recurrence over 5 years compared with when mesh was not used, although with long-term ...
Oct 18, 2016
A unique wearable artificial vision device may help people who are legally blind "read" and recognize faces. It may also help these individuals accomplish everyday tasks with significantly greater ease than using traditional ...
Oct 18, 2016
People who are unsuitable for LASIK because of moderate or extreme nearsightedness or severe astigmatism may benefit from a surgical procedure using intraocular lenses. Phakic intraocular collamer lenses, also called Phakic ...
Oct 18, 2016
Trauma centers that care for the greatest proportion of uninsured patients stand to gain the most financially from state expansion of the Medicaid program. Findings from the first nationwide examination of the anticipated ...
Oct 18, 2016
Researchers at The Saban Research Institute of Children's Hospital Los Angeles have identified an unsuspected and critical role of the MDM2 oncogene in promoting expression of the MYCN oncogene that is required for growth ...
Oct 18, 2016